Finally, An Experimental Covid-19 Vaccine Is In The Works

Published on

We could have a COVID-19 vaccine sooner than we expected.

According to reports by the Dailymail, pharmaceutical giant AstraZeneca has agreed to mass-produce a COVID-19 vaccine developed by Oxford University scientists.

Human trials of the experimental jab – called ChAdOx1 nCoV-19 – started last week and the first results are expected in mid-June.

If proven to be successful, the UK will be amongst the first countries to access the vaccine ‘as early as possible’, the university said in a statement.

Both partners have confirmed that the venture is not-for-profit and only the costs of production and distribution would be covered.

Developing vaccinations can take up to a decade and scientists have said finding an effective jab within 18 months would be ‘unprecedented’.

US Says There Is Evidence This Ebola Drug Can Help People Recover From Coronavirus


Related Stories